Byline: David DerbyshireDaily Mail (London)
Dr. Sanjay Razdan is an experienced robotic prostate surgeon in Miami, Florida & Chairman of the International Robotic Institute for Prostate Cancer.
In the U.S., prostate cancer is the most common cancer in men and is the second leading cause of cancer death in men (the first beinglung cancer). One man in 7 will be diagnosed with prostate cancer in their lifetime. In many cases it can be a slow moving disease and does not re...
Cancer survivors’ diets tend to be healthier Vigorous physical activity pays dividends in prostate cancer Doxycycline an antibiotic that attacks cancer stem cells Glutamate and prostate cancer Cancer patients have higher death rate from Covid Cutting sugar and glutamate starves cancer to death Testicular...
nadir PSA value by multivariate Cox regression analysis. The operation-related complications were minimal. Although both the period and number of patients were limited to evaluate the clinical efficacy, HIFU appears to be a safe and effective treatment option in selected patients with prostate cancer....
Prostate cancer (PCa) is the most commonly diagnosed male malignancy in the world with an incidence rate of 214 cases per 100,000 and a mortality rate from associated metastatic disease of 30 in 100,0001,2. The percentage of PCa amongst all male cancers is much higher in developed countries...
Our 3D Prostate Precision & Targeted Therapy is an advanced non-surgical, non-radiotherapy, non-chemotherapy, non-hormone, and very safe treatment without any side effects. Our treatment method can completely treat prostate cancer, prostatitis, enlarged
Median time to worsening health-related quality of life on the Functional Assessment of Cancer Therapy–Prostate questionnaire (5.7 vs 2.2 months; HR, 0.54; 95 % CI, 0.45–0.66) and pain intensity on the Brief Pain Inventory–Short Form (5.9 vs 2.2 months; HR, 0.52; 95 % CI...
(TRUS). Patients were excluded if they had undergone prior minimally invasive or surgical interventions on the prostate, had a prostate-specific antigen >10 ng/mL without a negative biopsy, had a diagnosis or suspicion of cancer in the prostate or bladder, or had a urinary tract diagnosis ...
The aim was to evaluate cancer-specific survival (CSS) and overall survival (OS) in patients with prostate cancer (PCa) recurrence who underwent salvage extended pelvic lymph node dissection (ePLND), taking into consideration pre- and postoperative androgen deprivation therapy (ADT). Methods Salvage...